- Home
- ATLC vs KURA Comparison
ATLC vs KURA Comparison
Compare ATLC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLC
- KURA
- Stock Information
- Founded
- ATLC 1996
- KURA 2014
- Country
- ATLC United States
- KURA United States
- Employees
- ATLC N/A
- KURA N/A
- Industry
- ATLC Finance: Consumer Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATLC Finance
- KURA Health Care
- Exchange
- ATLC Nasdaq
- KURA Nasdaq
- Market Cap
- ATLC 816.9M
- KURA 884.1M
- IPO Year
- ATLC 1999
- KURA N/A
- Fundamental
- Price
- ATLC $52.03
- KURA $10.73
- Analyst Decision
- ATLC Buy
- KURA Strong Buy
- Analyst Count
- ATLC 7
- KURA 13
- Target Price
- ATLC $78.71
- KURA $25.00
- AVG Volume (30 Days)
- ATLC 68.7K
- KURA 2.0M
- Earning Date
- ATLC 11-10-2025
- KURA 11-04-2025
- Dividend Yield
- ATLC N/A
- KURA N/A
- EPS Growth
- ATLC 26.57
- KURA N/A
- EPS
- ATLC 5.63
- KURA N/A
- Revenue
- ATLC $498,496,000.00
- KURA $104,029,000.00
- Revenue This Year
- ATLC $367.57
- KURA $68.63
- Revenue Next Year
- ATLC $35.94
- KURA $141.59
- P/E Ratio
- ATLC $9.19
- KURA N/A
- Revenue Growth
- ATLC 33.26
- KURA N/A
- 52 Week Low
- ATLC $41.37
- KURA $5.41
- 52 Week High
- ATLC $78.91
- KURA $19.73
- Technical
- Relative Strength Index (RSI)
- ATLC 40.01
- KURA 59.17
- Support Level
- ATLC $48.74
- KURA $9.45
- Resistance Level
- ATLC $58.59
- KURA $10.46
- Average True Range (ATR)
- ATLC 2.74
- KURA 0.76
- MACD
- ATLC -0.31
- KURA -0.01
- Stochastic Oscillator
- ATLC 25.75
- KURA 72.78
About ATLC Atlanticus Holdings Corporation
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.